News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
May 9, 2024, 00:16

Update CheckMate 9ER summarized by Sergio Cifuentes

Sergio Cifuentes, Cancer Research Project Manager at 

“Update CheckMate 9ER
– PFS: 16.6 m vs 8.4 m
– OS: 49.5 m vs 35.5 m (HR 0.70; 95% CI 0.56-0.87)
– CR: 13% vs 5%
– ORR: 56% (50-62%) vs 28% (23-33%)
– mDoR: 22.1 m vs 16.1 m

Benefit in intermediate/poor
Mexican Participation 35%”

Sergio Cifuentes

Proceed to the article.
Source: Sergio Cifuentes/X

cancer cancer therapy CheckMate 9ER clinical trial CR healthcare mDoR Medical Research Mexican participation OncoDaily Oncology ORR OS PFS Sergio Cifuentes treatment outcomes
Special Coverage
Blog
Dec 21, 2024, 19:42
Ruben Mesa: Over 200 research staff of Atrium Health Wake Forest Baptist trained on Just Ask Increasing Diversity in Cancer Clinical Trials
Blog
Dec 21, 2024, 19:39
Kyaw Thein: Investigational Treatments for Thyroid and Head and Neck Cancers
Blog
Dec 21, 2024, 19:25
Hesham ElGhazaly: From an academic institution into a globally recognized hub for healthcare, research and innovation
Blog
Dec 21, 2024, 19:21
Douglas Flora: The 19 Words I’m Learning to Embrace as a Leader in 2025
Blog
Dec 21, 2024, 19:19
Registration and abstract submission open for the PTCOG63 - SIOP Europe
Blog
Dec 21, 2024, 19:18
The Institute of Cancer Research's annual report for 2023-2024
Blog
Dec 21, 2024, 19:14
Pembrolizumab plus chemotherapy with or without bevacizumab for metastatic cervical cancer
Blog
Dec 21, 2024, 19:12
The International Cancer Control Partnership's latest global review of NCCPs is out now - NCI Center for Global Health
Blog
Dec 21, 2024, 18:59
Nominations for the SIOP Europe Lifetime Achievement are open
Blog
Dec 21, 2024, 18:57
Petra Ibum Adjah: Get your last self breast exams before the festivities begin
Blog
Dec 21, 2024, 18:54
Introducing Innovation at Your Fingertips - Total Health | Oncology
Insight
Dec 21, 2024, 18:46
Marengo Initiated Phase 2 Trial of Invikafusp Alfa for PD-1 Resistant Tumors, Expands to Europe